Attached files

file filename
S-1/A - S-1/A - CLARUS THERAPEUTICS INCa2201447zs-1a.htm
EX-3.3 - EX-3.3 - CLARUS THERAPEUTICS INCa2201631zex-3_3.htm
EX-4.1 - EXHIBIT 4.1 - CLARUS THERAPEUTICS INCa2201631zex-4_1.htm
EX-3.2 - EX-3.2 - CLARUS THERAPEUTICS INCa2201631zex-3_2.htm
EX-5.1 - EX-5.1 - CLARUS THERAPEUTICS INCa2201631zex-5_1.htm
EX-3.1 - EX-3.1 - CLARUS THERAPEUTICS INCa2201631zex-3_1.htm
EX-23.1 - EX-23.1 - CLARUS THERAPEUTICS INCa2201447zex-23_1.htm
EX-10.3 - EX-10.3 - CLARUS THERAPEUTICS INCa2201631zex-10_3.htm
EX-10.4 - EX-10.4 - CLARUS THERAPEUTICS INCa2201631zex-10_4.htm
EX-10.2 - EX-10.2 - CLARUS THERAPEUTICS INCa2201631zex-10_2.htm
EX-10.9 - EX-10.9 - CLARUS THERAPEUTICS INCa2201631zex-10_9.htm
EX-10.5 - EX-10.5 - CLARUS THERAPEUTICS INCa2201631zex-10_5.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 10.10

         GRAPHIC


CLARUS THERAPEUTICS, INC.
SENIOR EXECUTIVE INCENTIVE BONUS PLAN

1.
Purpose

        This Senior Executive Incentive Bonus Plan (the "Incentive Plan") is intended to provide an incentive for superior work and to motivate eligible executives of Clarus Therapeutics, Inc. (the "Company") and its subsidiaries toward even higher achievement and business results, to tie their goals and interests to those of the Company and its stockholders and to enable the Company to attract and retain highly qualified executives. The Incentive Plan is for the benefit of Covered Executives (as defined below).

2.
Covered Executives

        From time to time, the Compensation Committee of the Board of Directors of the Company (the "Compensation Committee") may select certain key executives (the "Covered Executives") to be eligible to receive bonuses hereunder.

3.
Administration

        The Compensation Committee shall have the sole discretion and authority to administer and interpret the Incentive Plan.

4.
Bonus Determinations

        (a)    A Covered Executive may receive a bonus payment under the Incentive Plan based upon the attainment of performance targets which are established by the Compensation Committee and relate to financial and operational metrics and clinical milestones with respect to the Company or any of its subsidiaries (the "Corporate Performance Goals"), including the following: revenues, expense levels, cash flow, clinical, regulatory, business development, and financing milestones and developments.

        (b)    Except as otherwise set forth in this Section 4(b): (i) any bonuses paid to Covered Executives under the Incentive Plan shall be based upon objectively determinable bonus formulas that tie such bonuses to one or more performance targets relating to the Corporate Performance Goals, (ii) bonus formulas for Covered Executives shall be adopted in each performance period by the Compensation Committee and communicated to each Covered Executive at the beginning of each performance period and (iii) no bonuses shall be paid to Covered Executives unless and until the Compensation Committee makes a determination with respect to the attainment of the performance objectives. Notwithstanding the foregoing, the Company may adjust bonuses payable under the Incentive Plan based on achievement of individual performance goals or pay bonuses (including, without limitation, discretionary bonuses) to Covered Executives under the Incentive Plan based upon such other terms and conditions as the Compensation Committee may in its discretion determine.

        (c)    Each Covered Executive shall have a targeted bonus opportunity for each performance period. For each Covered Executive, the Compensation Committee shall have the authority to apportion the annual target award so that a portion of the annual target award shall be tied to attainment of corporate performance targets and a portion of the target award shall be tied to attainment of individual performance targets.


        (d)    The payment of a bonus to a Covered Executive with respect to a performance period shall be conditioned upon the Covered Executive's employment by the Company on the last day of the performance period.

5.
Timing of Payment

        The Corporate Performance Goals will be measured at the end of each fiscal year after the Company's financial reports have been published. If the Corporate Performance Goals and or individual goals for any fiscal year are met, payments will be made as soon as practicable, but not later than March 15 of the subsequent fiscal year. For the avoidance of doubt, bonuses for year 1 must be paid by March 15 of year 2.

6.
Amendment and Termination

        The Company reserves the right to amend or terminate the Incentive Plan at any time in its sole discretion.

ADOPTED BY THE BOARD OF DIRECTORS: January 20, 2011

2




QuickLinks

CLARUS THERAPEUTICS, INC. SENIOR EXECUTIVE INCENTIVE BONUS PLAN